Lead Product(s) : D614G variant LNP-encapsulated mRNA Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Globe Biotech's BANCOVID Elicits Neutralizing Antibody and Balanced Cellular Immune Response
Details : The candidate mRNA vaccine ‘BANCOVID’ is a LNP–encapsulated, nucleoside-modified mRNA–based vaccine that encodes the SARS-CoV-2 spike (S) glycoprotein stabilized in its prefusion conformation.
Product Name : Bancovid
Product Type : Vaccine
Upfront Cash : Inapplicable
September 30, 2020
Lead Product(s) : D614G variant LNP-encapsulated mRNA Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable